NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
Peng Zhang(Huazhong University of Science and Technology), Yongwen Luo(Wuhan University)
Cited by 59
Related Papers
Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells
|International Journal of Oncology|2016|32